A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Type 2 Diabetes

Interventions

DRUG

exenatide once weekly

subcutaneous injection, once weekly

DRUG

placebo

subcutaneous injection, once weekly

Trial Locations (4)

Research Site, Fukuoka

Research Site, Kanagawa

Research Site, Osaka

Research Site, Tokyo